BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20472403)

  • 1. Comparison of clinical features, antimicrobial susceptibility, serotype distribution and outcomes of patients with hospital- and community-associated invasive pneumococcal disease.
    Lin SH; Liao WH; Lai CC; Tan CK; Liao CH; Huang YT; Wang CY; Hsueh PR
    Int J Antimicrob Agents; 2010 Aug; 36(2):119-23. PubMed ID: 20472403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
    Techasaensiri C; Messina AF; Katz K; Ahmad N; Huang R; McCracken GH
    Pediatr Infect Dis J; 2010 Apr; 29(4):294-300. PubMed ID: 19949357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
    Hsu KK; Shea KM; Stevenson AE; Pelton SI;
    Pediatr Infect Dis J; 2010 Apr; 29(4):289-93. PubMed ID: 19935447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ; McIntosh ED; Reinert RR
    Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in mortality and antibiotic resistance among HIV-infected patients with invasive pneumococcal disease.
    Grau I; Ardanuy C; Liñares J; Podzamczer D; Schulze MH; Pallares R
    HIV Med; 2009 Sep; 10(8):488-95. PubMed ID: 19459987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotype 6C is associated with penicillin-susceptible meningeal infections in human immunodeficiency virus (HIV)-infected adults among invasive pneumococcal isolates previously identified as serotype 6A in South Africa.
    du Plessis M; von Gottberg A; Madhi SA; Hattingh O; de Gouveia L; Klugman KP;
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S66-70. PubMed ID: 18723328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.
    Black S; France EK; Isaacman D; Bracken L; Lewis E; Hansen J; Fireman B; Austrian R; Graepel J; Gray S; Klein NP
    Pediatr Infect Dis J; 2007 Sep; 26(9):771-7. PubMed ID: 17721369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states.
    Imöhl M; Reinert RR; van der Linden M
    Int J Med Microbiol; 2010 Apr; 300(4):237-47. PubMed ID: 19604721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease.
    Weatherholtz R; Millar EV; Moulton LH; Reid R; Rudolph K; Santosham M; O'Brien KL
    Clin Infect Dis; 2010 May; 50(9):1238-46. PubMed ID: 20367225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotype changes in adult invasive pneumococcal infections in Portugal did not reduce the high fraction of potentially vaccine preventable infections.
    Horácio AN; Diamantino-Miranda J; Aguiar SI; Ramirez M; Melo-Cristino J;
    Vaccine; 2012 Jan; 30(2):218-24. PubMed ID: 22100892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
    Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance.
    Arifeen SE; Saha SK; Rahman S; Rahman KM; Rahman SM; Bari S; Naheed A; Mannan I; Seraji MH; Ahmed NU; Hassan MS; Huda N; Siddik AU; Quasem I; Islam M; Fatima K; Al-Emran H; Brooks WA; Baqui AH; Breiman RF; Sack D; Luby SP
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S103-13. PubMed ID: 19191605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?
    Fenoll A; Aguilar L; Granizo JJ; Giménez MJ; Aragoneses-Fenoll L; Mendez C; Tarragó D
    J Antimicrob Chemother; 2008 Dec; 62(6):1430-3. PubMed ID: 18819966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001-2003.
    Reinert RR; Haupts S; van der Linden M; Heeg C; Cil MY; Al-Lahham A; Fedson DS
    Clin Microbiol Infect; 2005 Dec; 11(12):985-91. PubMed ID: 16307552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.
    Pai R; Moore MR; Pilishvili T; Gertz RE; Whitney CG; Beall B;
    J Infect Dis; 2005 Dec; 192(11):1988-95. PubMed ID: 16267772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Invasive pneumococcal disease in Poland in 2010].
    Skoczyńska A; Kuch A; Gołebiewska A; Waśko I; Ronkiewicz P; Markowska M; Hryniewicz W
    Pol Merkur Lekarski; 2011 Aug; 31(182):80-5. PubMed ID: 21936342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.
    Shouval DS; Greenberg D; Givon-Lavi N; Porat N; Dagan R
    Pediatr Infect Dis J; 2009 Apr; 28(4):277-82. PubMed ID: 19258924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of serotypes and antibiotic resistance of invasive pneumococcal disease isolates among children aged 5 years and under in Saudi Arabia (2000-2004).
    Shibl AM
    Clin Microbiol Infect; 2008 Sep; 14(9):876-9. PubMed ID: 18844690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.